NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/22/2025
Back to search
Official data from USPTO
LONG BRIDGE MEDICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
07/22/2025
Trademark type
Combined
Nice classes
5, 10
Filing date
07/26/2023
Registration date
07/22/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/22/2025
Last transaction
07/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/02/2024
First use in commerce
12/02/2024
Drawing code
3
Owner type
03
Owner location
South San Francisco, CA, US
Examiner
WILLIS, ALLYSON B
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of Image of a bridge with the words "LONG BRIDGE" directly underneath the image, and the word "MEDICAL" directly under the word "BRIDGE".
Holders and representatives
Holders
Long Bridge Medical Inc.
Representatives
Andrew Ehard MERCHANT & GOULD P.C.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for treating chronic drug elutions to the eye sold pre-filled in medical devices for the eye that stablilizes and holds in position an intraocular lense
Class 10
Medical device for the eye that stabilizes and holds in position an intraocular lens
Publications
History of USPTO decisions and trademark events.
40 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/22/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/16/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/03/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/03/2025
ALIE
ASSIGNED TO LIE
07/03/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/23/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/19/2025
GNRT
NON-FINAL ACTION E-MAILED
05/19/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
05/19/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/15/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/15/2025
EISU
TEAS STATEMENT OF USE RECEIVED
02/26/2025
IUAF
USE AMENDMENT FILED
02/25/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/03/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/09/2024
PUBO
PUBLISHED FOR OPPOSITION
07/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/19/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/04/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
06/04/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/04/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
06/04/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/03/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/03/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/30/2024
GNRT
NON-FINAL ACTION E-MAILED
05/30/2024
CNRT
NON-FINAL ACTION WRITTEN
05/30/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/29/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/29/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/29/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/28/2024
GNRT
NON-FINAL ACTION E-MAILED
03/28/2024
CNRT
NON-FINAL ACTION WRITTEN
03/28/2024
DOCK
ASSIGNED TO EXAMINER
03/28/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/25/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/24/2023
NWAP
NEW APPLICATION ENTERED
07/29/2023
Continuous trademark protection
Get notified about every new filing that threatens LONG BRIDGE MEDICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.